Table.
Experimental group | A1 (μm) | A2 (μm) | pA3 (μm) | dA3 (μm) | A1 flow(nL/s) | FCD
capillary/field |
---|---|---|---|---|---|---|
Hemorrhagic shock + conventional resuscitation | 86 ± 3 | 40 ± 5 | 14 ± 1 | 11 ± 1 | 147 ± 6 | 5.5 ± 0.54 |
Hemorrhagic shock + conventional resuscitation + amiloride simultaneously with resuscitation | 89 ± 5 | 28 ± 4 | 14 ± 1 | 10 ± 1 | 145 ± 6 | 5.3 ± 0.19 |
Hemorrhagic shock + conventional resuscitation + amiloride preemptively at the beginning of hemorrhagic shock | 87 ± 3 | 38 ± 3 | 13 ± 1 | 9 ± 0.3 | 130 ± 11 | 5.2 ± 0.40 |
Hemorrhagic shock + conventional resuscitation + DPR | 92 ± 3 | 37 ± 5 | 12 ± 1 | 10 ± 0.4 | 160 ± 11 | 5.2 ± 0.34 |
Hemorrhagic shock + conventional resuscitation + DPR + amiloride simultaneously with resuscitation | 90 ± 3 | 35 ± 5 | 14 ± 1 | 10 ± 0.3 | 144 ± 12 | 4.5 ± 0.24 |
Sham control + amiloride | 87 ± 3 | 30 ± 4 | 13 ± 1 | 11 ± 1 | 161 ± 13 | 4.7 ± 0.24 |